Efficacy and safety of anti-PD-1 monotherapy versus anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience
Liu, Qingyan, Li, Rong, Li, Lingling, Wang, Gaokun, Ji, Shiyu, Zheng, Xuan, Jia, Xiaodong, Tao, Haitao, Hu, Yi
Published in Therapeutic advances in medical oncology (01.01.2023)
Published in Therapeutic advances in medical oncology (01.01.2023)
Get full text
Journal Article
IL-34 promotes foam cell formation by enhancing CD36 expression through p38 MAPK pathway
Liu, Qingyan, Fan, Jiao, Bai, Jing, Peng, Liang, Zhang, Tao, Deng, Lei, Wang, Gaokun, Zhao, Yu, Nong, Jingguo, Zhang, Minghua, Wang, Yu
Published in Scientific reports (26.11.2018)
Published in Scientific reports (26.11.2018)
Get full text
Journal Article
Efficacy and safety of anti-PD-1 monotherapy anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience
Qingyan Liu, Rong Li, Lingling Li, Gaokun Wang, Shiyu Ji, Xuan Zheng, Xiaodong Jia, Haitao Tao, Yi Hu
Published in Therapeutic advances in medical oncology (01.10.2023)
Published in Therapeutic advances in medical oncology (01.10.2023)
Get full text
Journal Article